13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • PERSIA

    Acronym: 

    PERSIA

    ACTRN/NCT /ethics: 

    Ethics: 163.18

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Breast
    Trial Type Treatment
    Phase All phases Tumour Stream Breast
    Age Range 18 years and older Cancer Stage All stages
    Sex Female Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Breast
    Trial Type Treatment
    Phase All phases
    Age Range 18 years and older
    Sex Female
    Molecular Target
    Tumour Stream Breast
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Pertuzumab study in the neoadjuv ant setting for HER2-positive non-metastatic breast cancer in Australia

    Lay Summary

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Ganessan Kichenadasse Not Yet Recruiting